[HBV and HCV infections among selected group of patients and staff members in the prospective study].
The aim of the study was the clinical and epidemiological evaluation of HBV and HCV infections among 96 patients with chronic renal failure entering dialysis programme, 31 patients with insulin-dependent diabetes and among staff members of Dialysis Unit (29 persons) and Department of Infectious Diseases (54 persons). In the group of haemodialyzed patients we have performed immuno-serological examinations every three months in the period of 18 months. During our study we have not observed any new seroconversion to anti-HCV. Among 66 HBsAg-negative patients 7 (10.6%) of them became HBsAg- and HBeAg-positive despite of active vaccination.
Urbanowicz
W
W
Katedra i Klinika Chorób Zakaźnych Pomorskiej Akademii Medycznej w Szczecinie.
D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D006526:Hepatitis C / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000150:complications / Q000534:rehabilitation; D011044:Poland / Q000453:epidemiology; D011446:Prospective Studies; D006435:Renal Dialysis